CVS Health Corp. (CVS) Financials
CVS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 253.0 billion | 175.3 billion |
| Dec. 31, 2025 | 261.1 billion | 185.7 billion |
| Sept. 30, 2025 | 255.3 billion | 182.2 billion |
| June 30, 2025 | 258.3 billion | 180.8 billion |
CVS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 3.4 billion | 266.0 million |
| Dec. 31, 2025 | 2.6 billion | 135.0 million |
| Sept. 30, 2025 | 98.0 million | -126.0 million |
| June 30, 2025 | 1.3 billion | 136.0 million |
CVS Net Income
| Date | Net Income |
|---|---|
| March 31, 2026 | 3.0 billion |
| Dec. 31, 2025 | 2.9 billion |
| Sept. 30, 2025 | -2.8 billion |
| June 30, 2025 | 1.0 billion |
CVS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 11.8 billion | 60.5 billion | 15.2 billion |
| Dec. 31, 2025 | 10.7 billion | 72.9 billion | 14.9 billion |
| Sept. 30, 2025 | 11.3 billion | 60.5 billion | 14.0 billion |
| June 30, 2025 | 14.2 billion | 57.3 billion | 16.2 billion |
CVS Shares Outstanding
CVS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 849.0 million | - | - | - |
| Dec. 31, 2025 | 784.0 million | - | - | - |
| Sept. 30, 2025 | 698.0 million | - | - | - |
| June 30, 2025 | 607.0 million | - | - | - |
CVS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 100.4 billion | 84.8 billion |
| Dec. 31, 2025 | 105.7 billion | 92.1 billion |
| Sept. 30, 2025 | 102.9 billion | 89.1 billion |
| June 30, 2025 | 98.9 billion | 85.3 billion |
CVS Revenue by Segment
CVS
Price: $110.60
Dividend Yield: 2.54%
Forward Dividend Yield: 2.41%
Payout Ratio: 47.33%
Dividend Per Share: 2.66 USD
Earnings Per Share: 2.28 USD
P/E Ratio: 40.45
Exchange: NYQ
Sector: Healthcare
Industry: Healthcare Plans
Country: United States
Volume: 7.3 million
Ebitda: 3.7 billionMarket Capitalization: 133.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 8.23%
DGR5: 5.94%
DGR10: 8.11%
DGR20: 16.50%